Influx Healthtech Ltd.
•₹ 2921.2%
2026-08-21
PROS
- Company is almost debt free
- Company has a healthy return on capital (ROCE) of 85.8%
- Company has a good return on equity (ROE) track record: 3 Years ROE 66.4%
- Operating margins have improved to 19.6% from 10.4%
- Company comfortably covers its interest (3576.8x coverage)
- Company generates healthy free cash flow
CONS
- Receivables are growing faster than sales - a possible quality concern
- Inventory has been piling up - inventory days up from 14 to 33
- Debtor days have increased from 54 to 84
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | INFLUX | 292.75 | 33.00 | 677.73 | 0.00 | — | — | — | — | 60.15 | — |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 59 | 76 | 100 | 105 | |
| 53 | 65 | 83 | 84 | |
| Operating Profit | 6 | 11 | 17 | 21 |
| OPM % | 10 | 14 | 17 | 20 |
| Other Income | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 1 | 2 | 3 |
| 6 | 10 | 15 | 18 | |
| Tax % | 26 | 26 | 25 | 25 |
| Net Profit | 4 | 7 | 11 | 13 |
| EPS | 1,775 | 2,878 | 4,451 | 7 |
| Dividend Payout % | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 |
| Adjusted EPS | 2 | 4 | 6 | 7 |
| Minority Interest | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 |
| Adjusted EPS | 2 | 4 | 6 | 7 |
Mar 2022
- 59
- 53
- Operating Profit
- 6
- OPM %
- 10
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 6
- Tax %
- 26
- Net Profit
- 4
- EPS
- 1,775
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2023
- 76
- 65
- Operating Profit
- 11
- OPM %
- 14
- Other Income
- 0
- Interest
- 0
- Depreciation
- 1
- 10
- Tax %
- 26
- Net Profit
- 7
- EPS
- 2,878
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
Mar 2024
- 100
- 83
- Operating Profit
- 17
- OPM %
- 17
- Other Income
- 0
- Interest
- 0
- Depreciation
- 2
- 15
- Tax %
- 25
- Net Profit
- 11
- EPS
- 4,451
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2025
- 105
- 84
- Operating Profit
- 21
- OPM %
- 20
- Other Income
- 0
- Interest
- 0
- Depreciation
- 3
- 18
- Tax %
- 25
- Net Profit
- 13
- EPS
- 7
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 21%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 44%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- 79%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 66%
- Last Year:
- 45%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| LIABILITIES | - | - | - | - |
| Equity Capital | 0 | 0 | 0 | 18 |
| 4 | 12 | 23 | 18 | |
| 0 | 1 | 0 | 0 | |
| Trade Payables | 11 | 13 | 14 | 29 |
| 2 | 2 | 4 | 4 | |
| Total Liabilities | 18 | 28 | 41 | 70 |
| ASSETS | - | - | - | - |
| 3 | 6 | 14 | 19 | |
| 2 | 2 | 5 | 13 | |
| 0 | 0 | 16 | 32 | |
| Cash & Bank | 1 | 4 | 4 | 2 |
| 12 | 16 | 2 | 4 | |
| Total Assets | 18 | 28 | 41 | 70 |
| Total Debt | 1 | 1 | 0 | 0 |
| Net Working Capital | 1 | 4 | 8 | 15 |
| Contingent Liabilities | 0 | 0 | 0 | 0 |
| Book Value per Share | 1782.92 | 4660.60 | 9111.76 | 19.91 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 1 | 1 | 0 | 0 |
| Net Working Capital | 1 | 4 | 8 | 15 |
| Contingent Liabilities | 0 | 0 | 0 | 0 |
| Book Value per Share | 1782.92 | 4660.60 | 9111.76 | 19.91 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2022
- Equity Capital
- 0
- 4
- 0
- Trade Payables
- 11
- 2
- Total Liabilities
- 18
- 3
- 2
- 0
- Cash & Bank
- 1
- 12
- Total Assets
- 18
- Total Debt
- 1
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 1782.92
- Face Value
- 10.00
- Total Debt
- 1
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 1782.92
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 0
- 12
- 1
- Trade Payables
- 13
- 2
- Total Liabilities
- 28
- 6
- 2
- 0
- Cash & Bank
- 4
- 16
- Total Assets
- 28
- Total Debt
- 1
- Net Working Capital
- 4
- Contingent Liabilities
- 0
- Book Value per Share
- 4660.60
- Face Value
- 10.00
- Total Debt
- 1
- Net Working Capital
- 4
- Contingent Liabilities
- 0
- Book Value per Share
- 4660.60
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 0
- 23
- 0
- Trade Payables
- 14
- 4
- Total Liabilities
- 41
- 14
- 5
- 16
- Cash & Bank
- 4
- 2
- Total Assets
- 41
- Total Debt
- 0
- Net Working Capital
- 8
- Contingent Liabilities
- 0
- Book Value per Share
- 9111.76
- Face Value
- 10.00
- Total Debt
- 0
- Net Working Capital
- 8
- Contingent Liabilities
- 0
- Book Value per Share
- 9111.76
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 18
- 18
- 0
- Trade Payables
- 29
- 4
- Total Liabilities
- 70
- 19
- 13
- 32
- Cash & Bank
- 2
- 4
- Total Assets
- 70
- Total Debt
- 0
- Net Working Capital
- 15
- Contingent Liabilities
- 0
- Book Value per Share
- 19.91
- Face Value
- 10.00
- Total Debt
- 0
- Net Working Capital
- 15
- Contingent Liabilities
- 0
- Book Value per Share
- 19.91
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 3 | 6 | 9 | 7 | |
| Cash from Investing | -3 | -5 | -8 | -9 |
| Cash from Financing | 1 | 0 | -1 | -0 |
| 1 | 2 | 0 | -2 | |
| Free Cash Flow | 3 | 2 | -0 | -1 |
| OCF / Net Profit | 0.66 | 0.89 | 0.80 | 0.53 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 |
| OCF / Net Profit | 0.66 | 0.89 | 0.80 | 0.53 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 |
Mar 2022
- 3
- Cash from Investing
- -3
- Cash from Financing
- 1
- 1
- Free Cash Flow
- 3
- OCF / Net Profit
- 0.66
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.66
- Cumulative 5-Year FCF
- 0
Mar 2023
- 6
- Cash from Investing
- -5
- Cash from Financing
- 0
- 2
- Free Cash Flow
- 2
- OCF / Net Profit
- 0.89
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.89
- Cumulative 5-Year FCF
- 0
Mar 2024
- 9
- Cash from Investing
- -8
- Cash from Financing
- -1
- 0
- Free Cash Flow
- -0
- OCF / Net Profit
- 0.80
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.80
- Cumulative 5-Year FCF
- 0
Mar 2025
- 7
- Cash from Investing
- -9
- Cash from Financing
- -0
- -2
- Free Cash Flow
- -1
- OCF / Net Profit
- 0.53
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.53
- Cumulative 5-Year FCF
- 0
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| PER SHARE | - | - | - | - |
| EPS (₹) | 1774.68 | 2877.68 | 4451.20 | 7.36 |
| Book Value (₹) | 1782.92 | 4660.60 | 9111.76 | 19.91 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 2.51 | 4.48 | 7.15 | 8.92 |
| PROFITABILITY | - | - | - | - |
| Operating Margin % | 10.42% | 14.11% | 16.97% | 19.62% |
| Net Margin % | 7.49% | 9.46% | 11.13% | 12.75% |
| ROE % | 99.54% | 89.32% | 64.64% | 45.37% |
| ROCE % | 119.35% | 111.85% | 85.26% | 60.15% |
| 25.23% | 31.35% | 32.20% | 24.10% | |
| EFFICIENCY | - | - | - | - |
| Debtor Days | 64 | 58 | 54 | 84 |
| Inventory Days | 11 | 9 | 14 | 33 |
| Payable Days | 114 | 112 | 104 | 183 |
| -39 | -45 | -36 | -67 | |
| FINANCIAL HEALTH | - | - | - | - |
| Debt to Equity (x) | 0.14x | 0.07x | 0.01x | 0.01x |
| Interest Coverage (x) | 144.68x | 163.54x | 67.66x | 3576.82x |
| 1.10x | 1.27x | 1.43x | 1.45x | |
| GROWTH | - | - | - | - |
| Revenue Growth % | 0.00% | 28.47% | 31.44% | 4.89% |
| Operating Profit Growth % | 0.00% | 73.97% | 58.48% | 21.74% |
| Net Profit Growth % | 0.00% | 62.15% | 54.68% | 20.11% |
| 0.00% | 0.00% | 54.68% | -99.83% | |
| VALUATION | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | -0.19x | 0.79x |
Mar 2022
- EPS (₹)
- 1774.68
- Book Value (₹)
- 1782.92
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.51
- Operating Margin %
- 10.42%
- Net Margin %
- 7.49%
- ROE %
- 99.54%
- ROCE %
- 119.35%
- 25.23%
- Debtor Days
- 64
- Inventory Days
- 11
- Payable Days
- 114
- -39
- Debt to Equity (x)
- 0.14x
- Interest Coverage (x)
- 144.68x
- 1.10x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 2877.68
- Book Value (₹)
- 4660.60
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.48
- Operating Margin %
- 14.11%
- Net Margin %
- 9.46%
- ROE %
- 89.32%
- ROCE %
- 111.85%
- 31.35%
- Debtor Days
- 58
- Inventory Days
- 9
- Payable Days
- 112
- -45
- Debt to Equity (x)
- 0.07x
- Interest Coverage (x)
- 163.54x
- 1.27x
- Revenue Growth %
- 28.47%
- Operating Profit Growth %
- 73.97%
- Net Profit Growth %
- 62.15%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 4451.20
- Book Value (₹)
- 9111.76
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 7.15
- Operating Margin %
- 16.97%
- Net Margin %
- 11.13%
- ROE %
- 64.64%
- ROCE %
- 85.26%
- 32.20%
- Debtor Days
- 54
- Inventory Days
- 14
- Payable Days
- 104
- -36
- Debt to Equity (x)
- 0.01x
- Interest Coverage (x)
- 67.66x
- 1.43x
- Revenue Growth %
- 31.44%
- Operating Profit Growth %
- 58.48%
- Net Profit Growth %
- 54.68%
- 54.68%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- -0.19x
Mar 2025
- EPS (₹)
- 7.36
- Book Value (₹)
- 19.91
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 8.92
- Operating Margin %
- 19.62%
- Net Margin %
- 12.75%
- ROE %
- 45.37%
- ROCE %
- 60.15%
- 24.10%
- Debtor Days
- 84
- Inventory Days
- 33
- Payable Days
- 183
- -67
- Debt to Equity (x)
- 0.01x
- Interest Coverage (x)
- 3576.82x
- 1.45x
- Revenue Growth %
- 4.89%
- Operating Profit Growth %
- 21.74%
- Net Profit Growth %
- 20.11%
- -99.83%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.79x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
May 2026
Nov 2025
Aug 2025